HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jerry Bagel Selected Research

calcipotriene (calcipotriol)

3/2022Adjunctive Use of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Patients With Psoriasis Treated With Ixekizumab.
12/2020Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis.
12/2020Apremilast with Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis.
8/2018A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy.
12/2017Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.
8/2016The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study.
1/2016Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
12/2015Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).
11/2014Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jerry Bagel Research Topics

Disease

62Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 03/2003
4Respiratory Tract Infections (Respiratory Tract Infection)
12/2021 - 08/2017
3Body Weight (Weight, Body)
06/2022 - 10/2015
3Nasopharyngitis
12/2021 - 04/2011
3Headache (Headaches)
12/2021 - 08/2017
3Pruritus (Itching)
12/2021 - 02/2020
3Diarrhea
01/2021 - 08/2017
2Atopic Dermatitis (Atopic Eczema)
06/2022 - 07/2021
2Inflammation (Inflammations)
07/2021 - 03/2015
2Infections
01/2021 - 01/2019
2Psoriatic Arthritis
02/2020 - 01/2018
2Erythema
12/2018 - 07/2012
2Nausea
02/2018 - 08/2017
2Vomiting
02/2018 - 08/2017
1Asthma (Bronchial Asthma)
06/2022
1Allergic Rhinitis
06/2022
1Obesity
01/2022
1Contact Dermatitis (Eczema, Contact)
12/2021
1Folliculitis (Sycosis)
12/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2021
1Whooping Cough (Pertussis)
07/2021
1Eczema
07/2021
1Human Influenza (Influenza)
07/2021
1Diphtheria
07/2021
1Tetanus
07/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Oral Candidiasis (Thrush)
01/2021
1Injection Site Reaction
02/2020
1Hypersensitivity (Allergy)
02/2020
1Chronic Disease (Chronic Diseases)
05/2018
1Weight Loss (Weight Reduction)
01/2018
1Overweight
01/2018
1Pain (Aches)
10/2017
1Drug-Related Side Effects and Adverse Reactions
01/2016
1Neutropenia
10/2015
1Candidiasis (Moniliasis)
10/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Virus Diseases (Viral Diseases)
01/2012

Drug/Important Bio-Agent (IBA)

14Biological ProductsIBA
02/2022 - 07/2005
9Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022 - 10/2009
9calcipotriene (calcipotriol)FDA LinkGeneric
03/2022 - 11/2014
9betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
03/2022 - 11/2014
8Prostaglandins AIBA
12/2021 - 04/2011
8apremilastIBA
12/2020 - 02/2017
7Etanercept (Enbrel)FDA Link
01/2021 - 03/2008
6Adalimumab (Humira)FDA Link
01/2021 - 04/2011
5secukinumabIBA
06/2022 - 10/2017
5Immunoglobulin A (IgA)IBA
06/2022 - 05/2018
5InterleukinsIBA
06/2022 - 03/2015
5halobetasol (ulobetasol)FDA LinkGeneric
02/2022 - 08/2018
5Interleukin-17 (Interleukin 17)IBA
01/2022 - 03/2015
5Tumor Necrosis Factor InhibitorsIBA
01/2021 - 01/2008
5Ustekinumab (CNTO 1275)FDA Link
02/2020 - 01/2012
4Monoclonal AntibodiesIBA
01/2022 - 10/2015
3ixekizumabIBA
03/2022 - 01/2016
3tazarotene (Tazorac)FDA Link
02/2022 - 08/2018
3brodalumabIBA
02/2020 - 10/2015
3Methotrexate (Mexate)FDA LinkGeneric
02/2020 - 01/2014
3AerosolsIBA
08/2016 - 12/2015
3Alefacept (Amevive)FDA Link
01/2008 - 03/2003
2guselkumabIBA
06/2022 - 08/2021
2bimekizumabIBA
02/2022 - 01/2021
2CytokinesIBA
07/2021 - 03/2015
2AcitretinFDA Link
02/2020 - 04/2015
2Cyclosporine (Ciclosporin)FDA LinkGeneric
02/2020 - 04/2015
2SteroidsIBA
02/2020 - 01/2009
2Infliximab (Remicade)FDA Link
01/2019 - 01/2008
2Desoximetasone (Topicort)FDA LinkGeneric
05/2018 - 12/2013
2Vitamin DFDA LinkGeneric
01/2018 - 12/2017
1dupilumabIBA
06/2022
1risankizumabIBA
06/2022
1tapinarofIBA
12/2021
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2021
1Interleukin-23 Subunit p19IBA
08/2021
1Meningococcal Vaccines (Meningococcal Vaccine)IBA
07/2021
1VaccinesIBA
07/2021
1Interleukin-13IBA
07/2021
1tralokinumabIBA
07/2021
1Interleukin-23 (Interleukin 23)IBA
01/2021
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1serlopitantIBA
06/2020
1Neurokinin-1 Receptor AntagonistsIBA
06/2020
1Pharmaceutical PreparationsIBA
02/2020
1Leflunomide (Arava)FDA LinkGeneric
02/2020
1Biosimilar PharmaceuticalsIBA
05/2018
1Betamethasone (Celestone)FDA Link
12/2017
1Ointments (Pastes)IBA
01/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2015
1Interleukin-12 (IL 12)IBA
03/2015
1SuspensionsIBA
11/2014

Therapy/Procedure

23Therapeutics
06/2022 - 07/2005
10Biological Therapy
06/2022 - 01/2008
9Phototherapy (Light Therapy)
02/2020 - 07/2006
2Injections
02/2022 - 01/2016
2Retreatment
02/2020 - 03/2003
2Subcutaneous Injections
01/2016 - 07/2012
1Self Administration (Administration, Self)
02/2022
1Polypharmacy
02/2020
1Excimer Lasers
01/2012